Ebos profit falls but dividend holds steady as Chemist Warehouse era ends

Ebos profit falls but dividend holds steady as Chemist Warehouse era ends
Ebos has invested about $360m in new facilities including room to store the increasingly popular weight loss drugs such as Wegovy. (Image: Getty)
Rebecca Stevenson
Ebos’ profit has fallen, but it will pay investors the same dividend as it moves on without the Chemist Warehouse contract. For the year to June 30, the health and animal care group reported revenue of A$12.3 billion (NZ$13.6b) and underlying earnings of A$585 million. Its guidance was for underlying earnings before interest, taxation, depreciation and amortisation (ebitda) of between A$575m and A$600m. Revenue dropped 7.0% compared to the previous financial year.  It lost the $1.9b Chemist Warehouse contract in 2023....

More Markets

Ebos CEO grilled on 'drastic' share-price fall
Markets

Ebos CEO grilled on 'drastic' share-price fall

Adam Hall's first AGM may well be the toughest he'll ever face.

RBNZ paying for unused floor space at new office
Property

RBNZ paying for unused floor space at new office

The Reserve Bank of NZ's plush new Britomart office will be only partially occupied. 

RBNZ cuts number of jobs by 20%
Finance

RBNZ cuts number of jobs by 20%

The Reserve Bank claims $11m of cost savings via Project Denby’s 20% job cuts.

Sky TV secures exclusive NZ broadcast rights for Olympic Games
Markets

Sky TV secures exclusive NZ broadcast rights for Olympic Games

Sky TV has secured exclusive New Zealand broadcast rights for the Olympic Games through to 2032.The agreement with the International Olympic Committee means Sky will televise the 2028 Summer Olympics in Los Angeles and 2032 in Brisbane, and the 2026 Winter Olympics in Milano Cort...